Enlarged prostate and Urosepsis

Summary:

Urosepsis is found among people with Enlarged prostate, especially for people who are 60+ old.

The study analyzes which people have Urosepsis with Enlarged prostate. It is created by eHealthMe based on reports of 93 people who have Enlarged prostate from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Enlarged prostate?

Enlarged prostate is found to be associated with 834 drugs and 1,399 conditions by eHealthMe. Check the latest studies of Enlarged prostate.

What is Urosepsis?

Urosepsis (secondary infection that occurs when a urinary tract infection spreads to the bloodstream) is found to be associated with 894 drugs and 920 conditions by eHealthMe. Check the latest studies of Urosepsis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 02, 2026

93 people who have Enlarged Prostate and Urosepsis are studied.

Would you have Urosepsis when you have Enlarged prostate?

Age of people who have Enlarged Prostate and experienced Urosepsis *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 9.76 %
  • 60+: 90.24 %

Common co-existing conditions for these people *:

  1. High Blood Pressure: 52 people, 55.91%
  2. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 32 people, 34.41%
  3. Gout (uric acid crystals building up in the body): 31 people, 33.33%
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 25 people, 26.88%
  5. Depression: 24 people, 25.81%
  6. Urinary Tract Infection: 24 people, 25.81%
  7. Asthma: 23 people, 24.73%
  8. Pain: 22 people, 23.66%
  9. Constipation: 20 people, 21.51%
  10. Sepsis (a severe blood infection that can lead to organ failure and death): 20 people, 21.51%

Common drugs taken by these people *:

  1. Tamsulosin: 30 people, 32.26%
  2. Amlodipine: 25 people, 26.88%
  3. Apixaban: 18 people, 19.35%
  4. Cordarone: 17 people, 18.28%
  5. Symbicort: 17 people, 18.28%
  6. Effexor: 17 people, 18.28%
  7. Furosemide: 13 people, 13.98%
  8. Ramipril: 12 people, 12.90%
  9. Allopurinol: 12 people, 12.90%
  10. Edoxaban: 11 people, 11.83%

Common symptoms for these people *:

  1. Urinary Tract Infection: 20 people, 21.51%
  2. General Physical Health Deterioration (weak health status): 19 people, 20.43%
  3. Intestinal Obstruction: 11 people, 11.83%
  4. Haematuria (presence of blood in urine): 10 people, 10.75%
  5. Thrombosis (formation of a blood clot inside a blood vessel): 10 people, 10.75%
  6. Cardiac Amyloidosis (protein deposition in heart): 10 people, 10.75%
  7. Small Intestinal Obstruction (blockage in small intestine): 10 people, 10.75%
  8. Helicobacter Infection (helicobacter pylori (h. pylori) infects stomach): 9 people, 9.68%
  9. Acute Kidney Failure: 8 people, 8.60%
  10. Anaemia (lack of blood): 7 people, 7.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Urosepsis?

- Check whether Urosepsis is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Urosepsis:

All the conditions that are associated with Urosepsis:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Urosepsis and Enlarged prostate, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: